Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments

Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs abundantly express somatostatin receptors. Consequently, following administration of somatostatin (SST) analogs labeled w...

Full description

Saved in:
Bibliographic Details
Main Authors: Bison, Sander M., Konijnenberg, Mark W., Melis, Marleen, Pool, Stefan E., Bernsen, Monique R., Teunissen, Jaap J. M., Kwekkeboom, Dik J., de Jong, Marion
Format: Artigo
Language:Inglês
Published: Springer Milan 2014
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3991004/
https://ncbi.nlm.nih.gov/pubmed/24765618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40336-014-0054-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items